Institutional Repository in Medical Sciences
(IRMS – Nicolae Testemițanu SUMPh)

Light therapy for seasonal affective disorder (sad): a meta analysis of efficacy

Show simple item record

dc.contributor.author Thayyil Ayisha
dc.date.accessioned 2024-10-28T12:50:28Z
dc.date.accessioned 2024-11-18T23:28:17Z
dc.date.available 2024-10-28T12:50:28Z
dc.date.available 2024-11-18T23:28:17Z
dc.date.issued 2024
dc.identifier.citation Thayyil Ayisha. Light therapy for seasonal affective disorder (sad): a meta analysis of efficacy. In: Abstract Book. MedEspera 2024. The 10th International Medical Congress for Students and Young Doctors. 24-27 April 2024, Chișinău, Republic of Moldova, p. 390. ISBN 978-9975-3544-2-4. en_US
dc.identifier.isbn 978-9975-3544-2-4
dc.identifier.uri https://ibn.idsi.md/collection_view/3104
dc.identifier.uri http://repository.usmf.md/handle/20.500.12710/28795
dc.description Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu”, Chişinău, Republica Moldova en_US
dc.description.abstract Introduction. Affective Disorder is a growing concern in mental health, and this study explores the effectiveness of light therapy. This meta-analysis delves into the efficacy of light therapy as a treatment for SAD. The research illuminates the diverse facets of SAD and its response to light therapy. Aim of study. This study explores dynamics of Seasonal Affective Disorder, emphasizing its connection with seasonal changes and the resulting psychological impact of depression. Going beyond conventional approaches, it aims to understand how light therapy alleviates associated depressive symptoms. Methods and materials. The research is conducted from sources like Google Scholar and ScienceDirect. Inclusion criteria prioritize studies specifically focused on light therapy for SAD. Results. To determine the efficacy of light therapy for Seasonal Affective Disorder, a metaanalysis of 19 trials' data was carried out by researchers. With a standardized mean difference for depression ratings of -0.37 and a risk ratio for treatment response of 1.42, bright light therapy appears to be superior to placebo. A study presented an innovative perspective by investigating exposure to outdoor light as a potential adjunct or alternative for traditional artificial light therapy for SAD. Interestingly, using strong placebo controls to compare white and green light treatments highlights the difficulties in distinguishing therapeutic benefits from placebos. Furthermore, a study concentrating on short-wavelength (blue) light treatment shows that it is more effective than dimmer red light for reducing major depressive disorder symptoms in a seasonal pattern. The metaanalysis contributes valuable insights to the evolving understanding of SAD treatment efficacy and highlights the need for larger, high-quality clinical trials to further substantiate these findings. Conclusion. This meta-analysis underscores the significance of light therapy as a viable treatment for SAD, providing valuable insights into its efficacy. The examination of existing research enhances our understanding of the role light therapy plays in addressing the psychological aspects of SAD, paving the way for informed interventions and future studies in this domain. the effectiveness of light therapy. This meta-analysis delves into the efficacy of light therapy as a treatment for SAD. The research illuminates the diverse f acets of SAD and its response to light therapy. Aim of study. This study explores dynamics of Seasonal Affective Diso rder, emphasizing its connection with seasonal changes and the resulting psyc hological impact of depression. Going beyond conventional approaches, it aims to understand how li ght therapy alleviates associated depressive symptoms. Methods and materials. The research is conducted from sources like Google Schola r and ScienceDirect. Inclusion criteria prioritize studies specifically focused on light therapy for SAD. Results. To determine the efficacy of light therapy for Season al Affective Disorder, a metaanalysis of 19 trials' data was carried out by researchers . With a standardized mean difference for depression ratings of -0.37 and a risk ratio for treatment response of 1.42, bright light therapy appears to be superior to placebo. A study presented an innovative perspective by investigating exposure to outdoor light as a potential adjunct or alternat ive for traditional artificial light therapy for SAD. Interestingly, using strong placebo controls to co mpare white and green light treatments highlights the difficulties in distinguishing therapeutic bene fits from placebos. Furthermore, a study concentrating on short-wavelength (blue) light trea tment shows that it is more effective than dimmer red light for reducing major depressive disorder sympt oms in a seasonal pattern. The metaanalysis contributes valuable insights to the evolving underst anding of SAD treatment efficacy and highlights the need for larger, high-quality clinical tri als to further substantiate these findings. Conclusion. This meta-analysis underscores the significance of light therapy as a viable treatment for SAD, providing valuable insights into its efficacy. The examination of existing research enhances our understanding of the role light therapy plays i n addressing the psychological aspects of SAD, paving the way for informed interventions and future st udies in this domain. en_US
dc.publisher Instituţia Publică Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu” din Republica Moldova en_US
dc.relation.ispartof MedEspera 2024 en_US
dc.title Light therapy for seasonal affective disorder (sad): a meta analysis of efficacy en_US
dc.type Other en_US


Files in this item

This item appears in the following Collection(s)

  • MedEspera 2024
    The 10th International Medical Congress for Students and Young Doctors, 24-27 April, 2024

Show simple item record

Search DSpace


Advanced Search

Browse

My Account

Statistics